Imran Sajjad is a Nephrology physician. OpenAlex indexes 9 publications with 800 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Industry payments
16 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20254 payments
- OPKO Pharmaceuticals, LLCProgram year20253 payments
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
45.3%Loop diuretic8.4%Furosemide66%Bumetanide30%Torsemide4%Part D<11 patientsBeta blocker7.9%Carvedilol70%Metoprolol Succinate21%Metoprolol Tartrate8%Bystolic2%Part D<11 patients+ 13 more classes in this area
Musculoskeletal
36.4%RANK Ligand Inhibitor34.2%Denosumab100%Part B, office-administered≥29 patientsXanthine oxidase inhibitor1.9%Allopurinol100%Part D≥45 patients+ 1 more class in this area
Metabolism & gastrointestinal
15.1%Vitamin D3 Analog8.5%Calcitriol100%Part D≥179 patientsPotassium supplement3.8%Potassium Chloride92%Klor-Con M208%Part D≥91 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Kidney Dysfunction and Cognitive Decline in Women
Clinical Journal of the American Society of Nephrology
2012 - Commercialization of Kidney Transplants: A Systematic Review of Outcomes in Recipients and Donors
American Journal of Nephrology
2008 - 227: Outcomes in Recipients and Donors of Commercial Kidney Transplantation
American Journal of Kidney Diseases
2008
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Andrew Levey, MD
Tufts Medical Center
Bertram Kasiske, MD
Hennepin Healthcare
Garabed Eknoyan, MD
Baylor College of Medicine
Lawrence Hunsicker, MD
University of Iowa
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”